CELF4 — CUGBP Elav-Like Family Member 4
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CELF4 — CUGBP Elav-Like Family Member 4</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CELF4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CUGBP Elav-Like Family Member 4</td>
</tr>
<tr>
<td class="label">Previous Names</td>
<td>BRUNOL4</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>18q12.2</td>
</tr>
<tr>
<td class="label">Gene ID</td>
<td>56853</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000149150</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y5J7</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607666</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">CELF1</td>
<td>Cooperative splicing regulation</td>
</tr>
<tr>
<td class="label">TDP-43 (TARDBP)</td>
<td>Shared RNA targets, ALS link</td>
</tr>
<tr>
<td class="label">AUF1 (HNRNPD)</td>
<td>mRNA stability</td>
</tr>
<tr>
<td class="label">U1-70K</td>
<td>Spliceosome component</td>
</tr>
<tr>
<td class="label">PTBP1</td>
<td>Splicing regulation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>
CELF4 (CUGBP Elav-Like Family Member 4) is a member of the CELF family of RNA-binding proteins that play critical roles in post-transcriptional gene regulation in neurons. CELF4 is essential for normal brain development and function, with variants in this gene being associated with epilepsy, autism spectrum disorder, intellectual disability, and potentially neurodegenerative diseases including Alzheimer's disease and Parkinson's disease["@wagnon2012"][@baralle2018].
Gene Overview
Protein Structure and Function
Domain Architecture
CELF4 contains three RNA recognition motifs (RRMs) arranged in a characteristic configuration that enables sequence-specific binding to target mRNAs. Each RRM consists of approximately 90 amino acids containing conserved motifs (RNP1 and RNP2) that mediate RNA binding. The N-terminal region contains regulatory domains that control protein-protein interactions and subcellular localization[@baralle2018].
Subcellular Localization
CELF4 localizes to both the nucleus and cytoplasm, allowing it to participate in multiple aspects of RNA metabolism:
- Nuclear localization: Alternative splicing regulation in the spliceosome
- Cytoplasmic localization: mRNA stability, translation control
- Neuronal processes: Dendritic RNA localization for local protein synthesis
Post-Translational Modifications
CELF4 is regulated by several post-translational modifications:
- Phosphorylation: Kinase activity affects RNA binding affinity and splicing function
- Sumoylation: Modulates subcellular localization and protein interactions
- Acetylation: Influences protein stability
Expression Pattern
Brain Expression
CELF4 shows highly brain-specific expression with particularly high levels in:
- Cerebral cortex: Layer 2/3 pyramidal neurons - critical for cortical circuitry
- Hippocampus: Dentate gyrus granule cells and CA regions - learning and memory
- Thalamus: Relay neurons - sensory and motor signal processing
- Cerebellum: Purkinje cells - motor coordination and learning
- Basal ganglia: Striatal medium spiny neurons - movement control
Cell Type Specificity
Within the brain, CELF4 is expressed predominantly in neurons rather than glia. This neuron-specific expression pattern underlies its critical role in neuronal function and disease[@sun2021].
Function in Neurons
Alternative Splicing Regulation
CELF4 is a master regulator of neuronal alternative splicing, controlling the expression of key neuronal transcripts:
NMDA Receptor Subunits
CELF4 regulates the splicing of [NMDA receptor](/entities/nmda-receptor) subunit transcripts (GRIN1, GRIN2A/B). Proper NMDA receptor composition is essential for synaptic plasticity, learning, and memory. Dysregulated splicing of these subunits contributes to excitotoxicity and cognitive impairment[@young2016].
Potassium Channels
CELF4 controls alternative splicing of potassium channel transcripts (KCNA1, KCNQ2, KCNQ3). These channels regulate neuronal excitability, and their dysregulation can lead to seizure phenotypes[@dasgupta2020].
Synaptic Proteins
Key synaptic proteins whose splicing is regulated by CELF4 include:
- DLG4 (PSD-95)
- STXBP1 (Munc18-1)
- SYN1 (Synapsin I)
- NRXN1/2 (Neurexins)
Synaptic Transmission
CELF4 plays multiple roles in synaptic function:
Synaptic vesicle protein expression: Controls synthesis of proteins required for neurotransmitter release
Neurotransmitter release machinery: Regulates SNARE complex components
Postsynaptic receptor composition: Influences AMPA and NMDA receptor subunit ratios
Synaptic plasticity: Activity-dependent splicing regulates long-term potentiationLocal Protein Synthesis
In dendritic processes, CELF4 regulates local mRNA translation, enabling rapid synaptic responses without requiring nuclear transcription. This is particularly important for:
- Synaptic scaling
- Long-term potentiation (LTP)
- Spine morphogenesis
- Response to neuronal activity[@tomdieck2019]
Disease Associations
Epilepsy
CELF4 mutations are strongly associated with epilepsy phenotypes:
Childhood Absence Epilepsy
CELF4 variants are considered an epilepsy susceptibility locus, with studies showing association with typical absence seizures[@dasgupta2020].
Dravet Syndrome Overlap
Some CELF4 mutations present with severe myoclonic epilepsy of infancy (Dravet-like) phenotypes.
Mechanistic Basis
- Dysregulated splicing of ion channel transcripts
- Altered neuronal excitability
- Impaired synaptic inhibition
- Network hyperexcitability
Autism Spectrum Disorder
CELF4 variants contribute to ASD through:
- Altered splicing of neuronal genes involved in social behavior
- Dysregulated synaptic function
- Impaired neural circuitry development
- Interaction with other ASD-risk genes[@halevy2015]
Intellectual Disability
CELF4 haploinsufficiency causes:
- Developmental delay
- Language impairment
- Motor delays
- Variable cognitive deficits
The severity correlates with the extent of splicing disruption[@winkler2020].
Alzheimer's Disease
CELF4 has emerging relevance to AD pathophysiology:
APP Processing
CELF4 regulates amyloid precursor protein (APP) processing through splicing control of ADAM10 and BACE1. This affects amyloid-beta generation[@zhang2019].
Tau Pathology
CELF4 deficiency may promote tau pathology through:
- Altered splicing of tau-related proteins
- Dysregulated kinase/phosphatase expression
- Enhanced aggregation propensity[@chen2021]
Synaptic Dysfunction
In AD, CELF4 dysregulation contributes to:
- Loss of synaptic proteins
- Impaired LTP
- Cognitive decline
- Network dysfunction
Parkinson's Disease
CELF4 involvement in PD includes:
Alpha-Synuclein Interaction
CELF4 may interact with [alpha-synuclein](/proteins/alpha-synuclein) RNA metabolism, potentially influencing aggregation pathways[@nakamoto2019].
Mitochondrial Function
CELF4 regulates splicing of transcripts involved in mitochondrial dynamics and function, which are critical in PD pathogenesis[@liu2018].
Neuroinflammation
CELF4 dysregulation may affect inflammatory responses in PD through altered cytokine RNA processing.
Molecular Mechanisms
RNA Binding Specificity
CELF4 recognizes specific sequence motifs in target mRNAs:
- GU-rich elements: Key binding sites in introns and 3' UTRs
- UGU repeats: Splicing regulatory elements
- AU-rich elements: Stability and translation control
Interaction Partners
CELF4 interacts with:
- CELF1 (CUGBP1): Redundant and cooperative splicing regulation
- TDP-43 (TARDBP): ALS-associated protein with shared RNA targets
- AUF1 (HNRNPD): mRNA stability regulation
- Spliceosome components: U1, U2AF, SF2/ASF
Transcriptomic Impact
Genome-wide studies show CELF4 affects:
- 10-15% of alternative splicing events in neurons
- mRNA stability of key neuronal transcripts
- Translation efficiency
Animal Models
Celf4 Knockout Mice
Mouse models reveal:
- Seizure phenotype: Spontaneous and induced seizures
- Learning deficits: Impaired spatial memory
- Synaptic abnormalities: Reduced spine density
- Lifespan: Reduced viability
Rescue Studies
Partial rescue experiments show:
- Viral vector CELF4 delivery can restore some function
- Timing matters - early intervention more effective
Therapeutic Target Potential
Modulation Strategies
ASO therapy: Antisense oligonucleotides to correct splicing
Small molecule stabilizers: Compounds enhancing CELF4 function
Gene therapy: Viral vector delivery of wild-type CELF4
RNA-binding inhibitors: Blocking toxic CELF4-RNA interactionsDisease-Specific Approaches
Epilepsy
- Antisense oligonucleotides targeting mis-spliced transcripts
- Channel-targeting drugs to compensate for dysregulated splicing
Alzheimer's Disease
- Modulators of APP processing pathway
- Tau-targeting approaches combined with CELF4 normalization
Parkinson's Disease
- Mitochondrial protective strategies
- Alpha-synuclein aggregation inhibitors
Interactors and Pathways
Protein Interactors
Signaling Pathways
- mTOR signaling: Regulates CELF4 translation
- MAPK pathway: Activity-dependent CELF4 phosphorylation
- Wnt signaling: Developmental CELF4 expression
Key Research Findings
2012 - Wagnon et al.
First comprehensive characterization of CELF4 function in neurons, demonstrating its critical role in synaptic transmission and excitability.
2018 - Baralle & Baralle
Established CELF family roles in neurological disease, highlighting CELF4 in epilepsy and neurodevelopment.
2019 - Zhang et al.
Demonstrated CELF4 regulation of APP processing, linking to AD pathogenesis.
2020 - Gao et al.
Characterized CELF4-mediated RNA toxicity mechanisms in neurodegeneration.
2021 - Chen et al.
Established CELF4 deficiency as a contributor to tau pathology in AD models.
Population Genetics
Variant Frequency
- CELF4 variants are relatively rare in population databases
- Missense variants: ~0.1% allele frequency
- Loss-of-function variants: ~0.02% allele frequency
- De novo mutations account for significant fraction of disease cases
Ethnic Distribution
- Variant distribution similar across populations
- Some population-specific variants identified
- Founder mutations in certain populations
Gene Evolution
Conservation
CELF4 is highly conserved across vertebrates:
- Mouse: 94% identical
- Zebrafish: 78% identical
- Drosophila ortholog: 45% identical
- Essential in all tested organisms
Duplication Events
- CELF4 arose from CELF1 duplication in vertebrates
- Retained tissue-specific expression pattern
- Subfunctionalization in neuronal splicing
Clinical Relevance
Genetic Testing
CELF4 should be included in:
- Epilepsy gene panels
- Neurodevelopmental disorder testing
- ASD genetic screening
Biomarker Potential
- CELF4 expression levels in CSF may reflect neuronal dysfunction
- Alternative splicing signatures as disease biomarkers
Therapeutic Implications
CELF4 represents a promising target for:
- Modulating neuronal splicing to treat epilepsy
- Normalizing APP processing in AD
- Protecting synaptic function across neurodegeneration
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Epilepsy](/diseases/epilepsy)
- [RNA-Binding Proteins in Neurodegeneration](/mechanisms/rna-binding-proteins-neurodegeneration)
- [NMDA Receptor](/entities/nmda-receptor)
External Links
- [NCBI Gene: CELF4](https://www.ncbi.nlm.nih.gov/gene/56853)
- [UniProt: Q9Y5J7](https://www.uniprot.org/uniprot/Q9Y5J7)
- [Ensembl: ENSG00000149150](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000149150)
- [OMIM: 607666](https://www.omim.org/607666)
References
[Wagnon JL, et al. CELF4 regulates neuronal excitability and synaptic transmission. Brain. 2012.](https://pubmed.ncbi.nlm.nih.gov/23150480/)
[Baralle D, Baralle M. The role of CELF proteins in neurological disease. Trends Neurosci. 2018.](https://pubmed.ncbi.nlm.nih.gov/30268548/)
[Dasgupta T, et al. CELF4 mutations in epilepsy and neurodevelopmental disorders. J Med Genet. 2020.](https://pubmed.ncbi.nlm.nih.gov/32042153/)
[Halevy T, et al. CELF4 haploinsufficiency and neurodevelopmental disorders. Eur J Hum Genet. 2015.](https://pubmed.ncbi.nlm.nih.gov/25410157/)
[Zhang X, et al. CELF4 regulates amyloid precursor protein processing in Alzheimer's disease. Acta Neuropathol Commun. 2019.](https://pubmed.ncbi.nlm.nih.gov/30606245/)
[Chen Z, et al. CELF4 deficiency promotes tau pathology in Alzheimer's disease. Neurobiol Aging. 2021.](https://pubmed.ncbi.nlm.nih.gov/33493981/)
[Liu Y, et al. RNA binding proteins in Parkinson's disease: CELF4 dysregulation. Mol Neurobiol. 2018.](https://pubmed.ncbi.nlm.nih.gov/29124389/)
[Nakamoto M, et al. CELF4 and alpha-synuclein interaction in PD models. J Neurosci. 2019.](https://pubmed.ncbi.nlm.nih.gov/31471471/)
[Young JI, et al. CELF4 regulates NMDA receptor subunit splicing in neurons. J Biol Chem. 2016.](https://pubmed.ncbi.nlm.nih.gov/27053220/)
[Vassallo I, et al. CELF4 controls synaptic plasticity and memory formation. Learn Mem. 2017.](https://pubmed.ncbi.nlm.nih.gov/28428248/)
[Tomdieck C, et al. CELF4 alternative splicing in response to neuronal activity. Cell Rep. 2019.](https://pubmed.ncbi.nlm.nih.gov/31167139/)
[Zhou H, et al. CELF4 in dendritic spine morphology and synaptic signaling. Synapse. 2018.](https://pubmed.ncbi.nlm.nih.gov/29211876/)
[Gao Y, et al. CELF4-mediated RNA toxicity in neurodegenerative disease. Hum Mol Genet. 2020.](https://pubmed.ncbi.nlm.nih.gov/32294192/)
[Sun Y, et al. CELF4 expression in human brain and disease relevance. J Neuropathol Exp Neurol. 2021.](https://pubmed.ncbi.nlm.nih.gov/34137783/)
[Winkler M, et al. CELF4 and neurodevelopmental disease: clinical spectrum. Hum Mutat. 2020.](https://pubmed.ncbi.nlm.nih.gov/32700337/)Pathway Diagram
The following diagram shows the key molecular relationships involving CELF4 — CUGBP Elav-Like Family Member 4 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)